Novartis AG - NVS (NYSE)

76.32
0.15 (0.21%)
Quotes delayed 15 mins. Currently May 25, 2018 12:30:03 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Novartis provides branded and generic medicines, diagnostic tools and consumer health products

Key Financials

Day Range:76.12 - 76.83
52 Week Range:75.73 - 94.19
Open:76.68
Shares:2.33B
Market Cap:177.88B
EPS:3.41
P/E Ratio:22.40
Div Yield:3.86
Performance
Previous close
No Chart Available
Purchase NVS in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of NVS not only as a single stock, but also as part of a motif.
Professional Motifs with NVS
Battling Cancer
Battling Cancer 29.1% 1 YR RTN New drugs and devices could be a game-changer for the war on the nation's second-biggest killer.
View all professional motifs with NVS
Community Motifs with NVS
Rising drug costs
Rising drug costs 2.9% 1 YR RTN
Big Pharma
Big Pharma 5.2% 1 YR RTN
Pharma/Drug PhRMAA
Pharma/Drug PhRMAA 3.2% 1 YR RTN
Pharma Rebounce Bet
Pharma Rebounce Bet 7.9% 1 YR RTN
View all community motifs with NVS
What Others Think About NVS
Matthew Herper
I spoke to former $NVS chief executive Joe Jimenez about the decision to hire Michael Cohen. Here's what he said. forbes.com/sites/matthewh…
47 58
John Carroll
Interesting night --
The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and mor… twitter.com/i/web/status/9…
17 29
Dicky Chan
RT @rago_carlo : 10 reasons I like my long position in $NWBO #DCVax @NorthwestBio going into #ASCO18
2 of 10: NWBO CEO et al sold their sta…
2
Nipsy Gussell
Cohen scandal disrupts ex-Novartis CEO's move to hedge fund board: WSJ fiercepharma.com/pharma/scandal… Jim Jimenez #asshattwitter.com/i/web/status/1…
The Lincolnian
Novartis $NVS Upgraded at Credit Suisse Group thelincolnianonline.com/?p=1763271
Related Companies Within The Drug Manufacturers - Major Sector
JNJ
Pfizer Inc. - 35.60
PFE
ABBV
AbbVie Inc. - 100.94
ABBV
GSK